Clinical trial
A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
NCT05635266 is registered in ClinicalTrials.gov with Sanguine Biosciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
- Lead sponsor
- Sanguine Biosciences
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 26, 2021
- Completion date
- October 31, 2025
- Enrollment
- 20,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
age-related macular degeneration, allergies, alopecia areata, alpha-gal syndrome, als, alzheimer disease, amyloidosis, ankylosing spondylitis, arthritis, asthma, atopic dermatitis, autism, autoimmune hepatitis, behcet's disease, beta-thalassemia, cancer, celiac disease, cirrhosis, copd, crohn disease, cystic fibrosis, diabetes, dmd, dravet syndrome, fibromyalgia, graves disease, heart diseases, hepatitis, hidradenitis suppurativa, itp, kidney diseases, leukemia, lupus or sle, lymphoma, multiple sclerosis, myasthenia gravis, parkinson disease, pemphigus vulgaris, psoriasis, schizophrenia, scleroderma, sickle cell disease, stroke, thyroid diseases, ulcerative colitis, vasculitis, vitiligo